C4 Therapeutics Inc (CCCC) Stock Price, Quote, News & History

CCCCNASDAQ
$3.46
0.041.17%
Last update: Sep 18, 11:40 AM

C4 Therapeutics (CCCC) Stock Price, Quote, News & History | Benzinga

Loading...

Key Statistics

Open
$3.43
Close
-
Volume / Avg.
304.17K / 2.93M
Day Range
$3.40 - $3.48
52 Wk Range
1.69 - 5.17
Market Cap
$425.05M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
39
Short Interest
30.59%
Days to Cover
16.74

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-84.87M
Investing Cash Flow (TTM)
-75.31M
Financing Cash Flow (TTM)
160.63M
Free Cash Flow (TTM)
-85.39M
Capital Expenditure (TTM)
-523.00K
Net Change in Cash (TTM)
453.00K

Analyst Trends and Forecast

1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$222.71M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
10.86
PB Ratio (TTM)
1.70
Earnings Yield % (TTM)
-26.69%
Earnings Yield % (FWD)
-27.27%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.01

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$78.61M
Debt to Equity
0.23
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.43
Close
-
Volume / Avg.
304.17K / 2.93M
Day Range
$3.40 - $3.48
52 Wk Range
1.69 - 5.17
Market Cap
$425.05M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
39
Short Interest
30.59%
Days to Cover
16.74

About

Sector
Health Care
Industry
Biotechnology
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targe...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy C4 Therapeutics (CCCC) stock?

A

You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are C4 Therapeutics (CCCC) competitors?

Q

What is the forecast, or price target, for C4 Therapeutics (CCCC) stock?

A

C4 Therapeutics has a consensus price target of $10.83.

Q

What is the current price for C4 Therapeutics (CCCC)?

A

The stock price for C4 Therapeutics (NASDAQ: CCCC) is $3.455 last updated September 18, 2026 at 11:40 AM EDT.

Q

Does C4 Therapeutics (CCCC) pay a dividend?

A

There are no upcoming dividends for C4 Therapeutics.

Q

When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?

A

C4 Therapeutics does not have any upcoming earnings scheduled.

Q

Is C4 Therapeutics (CCCC) going to split?

A

There is no upcoming split for C4 Therapeutics.

Q

What sector and industry does C4 Therapeutics (CCCC) operate in?

A

C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.